9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

Alanosine in Treating Patients With Cancer

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > Alanosine in Treating Patients With Cancer

Alanosine in Treating Patients With Cancer

Estimated reading time: < 1 min

Condition: Lung Cancer

Estimated Enrollment:

Gender: All

Min Age: 13 Years

Age Group: Child, Adult

Current Status: Completed

Study Results: No Results Available

Outcome Measures: ,  ,  ,

Interventions: L-alanosine,

Phase:

Study Type: Interventional

Study Design: Masking: None (Open Label), Primary Purpose: Treatment, ,

Primary Completion Date: December 2005

Completion Date: December 2009

Last  Posted Date: June 26, 2013

Location: University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States

Website Link: https://ClinicalTrials.gov/show/NCT00062283

Was this article helpful?
Dislike 0